A. L. Bloom 2026-11-05
A. L. Bloom was a coagulation researcher who, with J. C. Giddings, investigated how activated Factor V promotes production of thrombin. Their 1975 study reconstructed the reaction using purified coagulation factors.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Byline and Abstract: purified-factor experiments
Pretreating Factor V with trace amounts of thrombin increased the rate and yield of subsequent thrombin generation from prothrombin. The finding supported a positive feedback mechanism: product formation could enhance further product formation by activating a cofactor.[ref]
Factor V 2026-11-05
Factor V is a coagulation factor whose activated form, factor Va, is a protein cofactor in the prothrombinase complex. Limited proteolysis, including cleavage by thrombin, converts Factor V into the more active cofactor. In the assembled complex, factor Xa performs the cleavage of prothrombin to thrombin; factor Va helps the reaction occur efficiently on a phospholipid surface in the presence of calcium ions.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract: thrombin pretreatment and reconstitution from purified components
The distinction between precursor and activated cofactor matters experimentally. Investigators mixed purified coagulation factors, separated the products by gel chromatography, and identified components with specific antibodies. Pretreating Factor V with small amounts of thrombin increased the rate and yield of subsequent thrombin generation. A little product could therefore promote production of more product: a positive feedback mechanism within coagulation.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract: column fractions, immunological analysis, and kinetic experiments
Factor Va 2026-11-05
Factor Va is the activated form of Factor V that serves as a protein cofactor for factor Xa during prothrombin activation. In the membrane-associated complex, factor Xa supplies the proteolytic catalyst while factor Va helps organize efficient conversion to thrombin.[ref]
Crystal Structure of Prothrombin Reveals Conformational Flexibility and Mechanism of Activation by Nicola Pozzi and others. Introduction: prothrombinase components and substrate interactions
The cofactor's effect can be measured by reconstituting the reaction from purified components. In a bovine study with one defined phospholipid mixture, adding factor Va reduced the apparent Michaelis constant for prothrombin from to . Other vesicle compositions gave different relationships between binding and apparent kinetics.[ref]
Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on formation of the enzyme-substrate complex by J. L. van Rijn and others. Abstract: vesicles with 20 mole percent phosphatidylglycerol and 80 mole percent phosphatidylcholine
The ratio describes the change in that apparent kinetic parameter. It does not imply that every reaction rate rises 55-fold: the observed rate also depends on substrate abundance and the limiting rate. The example shows how a noncatalytic protein can strongly regulate an enzyme reaction by participating in its molecular assembly.
J. C. Giddings 2026-11-05
J. C. Giddings is the coagulation researcher who coauthored the 1975 study of Factor V activation and prothrombin conversion with A. L. Bloom. The work investigated both assembly of reaction components and production of thrombin.[ref]
Gel chromatography separated the preparations, and specific antibodies helped identify components in the resulting fractions. Combined with kinetic measurements, these experiments supported a functional assembly involving phospholipids, Factor V, factor Xa and calcium ions.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract: Sephadex chromatography, immunological analysis and thrombin-generation tests
This illustrates two complementary questions: which molecules associate, and does their association support the expected reaction? Component identification addresses composition; an activity assay addresses function. Using both provides a stronger explanation than either separation or product measurement alone.
Prothrombinase complex 2026-11-05
The prothrombinase complex is a membrane-associated assembly that converts prothrombin into thrombin. Its catalytic enzyme is factor Xa, assisted by the protein cofactor factor Va, calcium ions, and a phospholipid surface. The protease and its assembled reaction system are distinct: factor Va helps organize efficient prothrombin conversion without replacing the catalytic role of factor Xa.[ref]
Coagulation factor Xa EC 3.4.21.6 in IUBMB Enzyme Nomenclature. Comments; factor Xa, factor Va, calcium and phospholipids in prothrombin conversion
Experiments in 1975 combined purified coagulation components and used chromatography to separate the material formed. Tests with specific antibodies helped identify the factors in the collected fractions, and kinetic measurements established that the assembled preparation converted purified prothrombin into thrombin. These supplied different kinds of evidence: association of components, and catalytic activity.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. British Journal of Haematology 29, pp. 349–364; abstract, Sephadex fractionation, antibody analysis and purified-factor kinetics
Pretreating Factor V with trace amounts of thrombin increased the subsequent rate and yield of thrombin production. This illustrates positive feedback: a product of the reaction helps activate a component that promotes further product formation. A single observed rate increase would not establish complex composition; the fractionation and identification experiments addressed that separate question.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract; thrombin pretreatment of factor V and subsequent thrombin generation